These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10553173)

  • 1. A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor.
    Gandini G; Franchini M; Manzato F; Lippi G; Aprili G
    Haematologica; 1999 Nov; 84(11):1054. PubMed ID: 10553173
    [No Abstract]   [Full Text] [Related]  

  • 2. Double carriers of the factor V Leiden and prothrombin (FIIG20210A) mutations: a description of four cases.
    González Ordóñez AJ; Sánchez LM; Medina Rodríguez JM; Martínez Muñiz MA; Menéndez Caro JL; Alvarez MV
    Haematologica; 1999 Nov; 84(11):1054-6. PubMed ID: 10553174
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between subcutaneous and intravenous DDAVP in mild and moderate hemophilia A.
    De Sio L; Mariani G; Muzzucconi MG; Chistolini A; Tirindelli MC; Mandelli F
    Thromb Haemost; 1985 Aug; 54(2):387-9. PubMed ID: 3936212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful cyclosporin therapy of acquired hemophilia caused by factor VIII (VIII:C) inhibiting antibody].
    Pfliegler G; Boda Z; Hársfalvi J; Flóra-Nagy M; Sári B; Pecze K; Rák K
    Orv Hetil; 1991 Jul; 132(27):1485-8. PubMed ID: 1956679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression of patients with acquired factor VIII inhibitors.
    Green D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion.
    Frank RD; Kunz D; Wirtz DC
    Am J Hematol; 2002 May; 70(1):64-71. PubMed ID: 11994985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDAVP in acquired hemophilia A: case report and review of the literature.
    Mudad R; Kane WH
    Am J Hematol; 1993 Aug; 43(4):295-9. PubMed ID: 8372811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin therapy in patients with acquired factor VIII inhibitors.
    Naorose-Abidi SM; Bond LR; Chitolie A; Bevan DH
    Lancet; 1988 Feb; 1(8581):366. PubMed ID: 2893182
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acquired factor VIIIc inhibitors. Two cases and a review of the literature].
    Bayani N; Lelong F
    Ann Med Interne (Paris); 2001 Apr; 152(3):201-8. PubMed ID: 11431582
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.
    Gill JC; Ottum M; Schwartz B
    J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine.
    Famularo G; De Maria S; Minisola G; Nicotra GC
    Ann Pharmacother; 2004 Sep; 38(9):1432-4. PubMed ID: 15266042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A rare disease but with a very high hemorrhagic risk: acquired hemophilia A].
    Delisle V; Ternisien C; Beurrier P; Zandecki M
    Ann Biol Clin (Paris); 2000; 58(6):741-4. PubMed ID: 11098173
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid elimination of a high-titered F VIII inhibitor by high dose recombinant F VIII combined with high dose immunoglobulin infusion.
    Mauz-Korholz C; Korholz D; Gobel U
    Thromb Haemost; 1997 Aug; 78(2):959. PubMed ID: 9268203
    [No Abstract]   [Full Text] [Related]  

  • 18. [DDAVP and its effect on factor VIII activity (author's transl)].
    Sikorová J; Vorlová Z
    Cas Lek Cesk; 1981 May; 120(18):553-6. PubMed ID: 6794913
    [No Abstract]   [Full Text] [Related]  

  • 19. [Refractory acquired hemophilia A successfully treated with CVP].
    Kaneko H; Okada N; Matsui Y; Nishizawa M; Watanabe M; Miura Y; Tsudo M
    Rinsho Ketsueki; 2009 Feb; 50(2):110-2. PubMed ID: 19265305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders.
    Khair K; Baker K; Mathias M; Burgess C; Liesner R
    Haemophilia; 2007 Sep; 13(5):548-51. PubMed ID: 17880442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.